Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/s0140-6736(15)60292-6 | Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial |
| https://doi.org/10.1161/circulationaha.117.029289 | Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document |
| https://doi.org/10.1016/j.jacc.2015.05.049 | Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions |
| https://doi.org/10.1056/nejmoa2108749 | Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk |
| https://doi.org/10.1056/nejmoa1911425 | A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement |
| https://doi.org/10.1097/hjr.0b013e328334f42d | Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey |
| https://doi.org/10.1056/nejmoa1507854 | Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes |
| https://doi.org/10.1093/eurheartj/ehy223 | Standardized End Point Definitions for Coronary Intervention Trials |
| https://doi.org/10.1093/eurjpc/zwab007 | Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology |
| https://doi.org/10.1016/s0140-6736(18)31714-8 | Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial |
| https://doi.org/10.1136/bmj.n1332 | P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials |
| https://doi.org/10.1177/2047487316676042 | Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE |
| https://doi.org/10.1093/eurjhf/hfr144 | Effect of a Telemonitoring-Facilitated Collaboration Between General Practitioner and Heart Failure Clinic on Mortality and Rehospitalization Rates in Severe Heart Failure: The TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) Study |
| https://doi.org/10.1093/eurheartj/ehv333 | Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions |
| https://doi.org/10.1016/j.jacc.2009.11.049 | 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions |
| https://doi.org/10.1016/s0140-6736(11)60395-4 | Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial |
| https://doi.org/10.1016/j.jacc.2016.05.067 | Standardization of Fractional Flow Reserve Measurements |
| https://doi.org/10.1093/europace/euw243 | Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE |
| https://doi.org/10.1177/2048872619894254 | Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology |
| https://doi.org/10.1002/humu.24004 | A mutation update for the FLNC gene in myopathies and cardiomyopathies |
| https://doi.org/10.1093/europace/euac062 | Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference |
| https://doi.org/10.1177/2047487316663873 | Challenges in secondary prevention after acute myocardial infarction: A call for action |
| https://doi.org/10.1016/j.jacc.2019.05.016 | Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI |
| https://doi.org/10.1016/j.jacc.2013.12.036 | 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents |
| https://doi.org/10.1016/j.jacc.2017.02.070 | Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management |
| https://doi.org/10.1177/2047487319846715 | Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) |
| https://doi.org/10.1016/j.jacc.2019.08.1038 | Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting |
| https://doi.org/10.1161/circulationaha.121.057859 | Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial |
| https://doi.org/10.1093/europace/euy215 | Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling |
| https://doi.org/10.1093/eurheartj/ehad152 | Lifelong endurance exercise and its relation with coronary atherosclerosis |
| https://doi.org/10.1001/jamacardio.2019.3355 | Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes |
| https://doi.org/10.1093/eurheartj/ehac706 | Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials |
| https://doi.org/10.15420/aer.2017.50.1 | The Significance of Drug–Drug and Drug–Food Interactions of Oral Anticoagulation |
| https://doi.org/10.1093/eurheartj/ehz453 | Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial |
| https://doi.org/10.1016/j.jacc.2020.11.046 | Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes |
| https://doi.org/10.1161/jaha.114.000789 | Prognostic Value of Left Ventricular Diastolic Dysfunction in a General Population |
| https://doi.org/10.1038/s41569-019-0314-y | Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease |
| https://doi.org/10.1016/j.jacc.2022.11.041 | P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions |
| https://doi.org/10.1002/ejhf.70 | Combined Aerobic/Inspiratory Muscle Training vs. Aerobic Training in Patients with Chronic Heart Failure |
| https://doi.org/10.1186/2049-3258-72-47 | Reliability and Validity of the Dutch Physical Activity Questionnaires for Children (PAQ-C) and Adolescents (PAQ-A) |
| https://doi.org/10.1093/eurjpc/zwac204 | How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology |
| https://doi.org/10.1016/j.jacc.2016.02.056 | Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes |
| https://doi.org/10.4244/eijy15m11_07 | Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial |
| https://doi.org/10.1016/s0140-6736(24)01616-7 | De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials |
| https://doi.org/10.1016/j.ahj.2016.10.017 | Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study |
| https://doi.org/10.1016/j.ijcard.2016.11.059 | Exercise-based cardiac rehabilitation in twelve European countries results of the European cardiac rehabilitation registry |
| https://doi.org/10.1001/jamacardio.2024.0133 | Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention |
| https://doi.org/10.1093/eurheartj/ehy377 | Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC) |
| https://doi.org/10.1016/j.ahj.2017.10.009 | Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial |
| https://doi.org/10.1093/eurheartj/ehv038 | Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial |
| https://doi.org/10.1093/eurheartj/ehac284 | Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis |
| https://doi.org/10.1016/j.jcin.2011.02.018 | A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials |
| https://doi.org/10.1161/circulationaha.121.056680 | Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial |
| https://doi.org/10.1093/eurjpc/zwae070 | Cardiovascular disease as part of Long COVID: a systematic review |
| https://doi.org/10.1093/eurheartj/ehx390 | Thrombo-embolic prevention after transcatheter aortic valve implantation |
| https://doi.org/10.1056/nejmoa2509688 | Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation |
| https://doi.org/10.1093/eurheartj/ehx048 | Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation |
| https://doi.org/10.1093/ehjcvp/pvaa009 | Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) |
| https://doi.org/10.1093/ehjcvp/pvad032 | Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease |
| https://doi.org/10.1002/ejhf.2286 | Cardiac, Renal, and Metabolic Effects of Sodium–Glucose Co-Transporter 2 Inhibitors: A Position Paper from the European Society of Cardiology Ad-Hoc Task Force on Sodium–Glucose Co-Transporter 2 Inhibitors |
| https://doi.org/10.1093/europace/euad176 | The digital journey: 25 years of digital development in electrophysiology from an Europace perspective |
| https://doi.org/10.1016/j.ahj.2018.10.009 | Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study |
| https://doi.org/10.1177/2048872620924922 | The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions |
| https://doi.org/10.1161/circulationaha.122.063777 | Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy |
| https://doi.org/10.1177/2048872619858285 | Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) |
| https://doi.org/10.1093/eurheartj/ehae363 | Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery |
| https://doi.org/10.1016/j.jchf.2022.11.004 | Cardiopulmonary Exercise Testing With Simultaneous Echocardiography |
| https://doi.org/10.1016/j.jcin.2020.11.042 | Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management |
| https://doi.org/10.1093/eurjpc/zwab160 | European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology |
| https://doi.org/10.1161/circulationaha.124.069012 | Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome |
| https://doi.org/10.1093/eurheartj/ehae927 | Coronary atherosclerosis in athletes: emerging concepts and preventive strategies |
| https://doi.org/10.1093/eurheartj/ehaf408 | Standards for cardiac telerehabilitation |
| https://doi.org/10.1093/ehjcvp/pvad016 | Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC) |
| https://doi.org/10.1016/j.jcin.2023.02.027 | Impact of Preprocedural Computed Tomography on Left Atrial Appendage Closure Success |
| https://doi.org/10.1093/ehjdh/ztae042 | Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee |
| https://doi.org/10.1016/j.jacc.2023.06.047 | Generalized Pairwise Comparisons to Assess Treatment Effects |
| https://doi.org/10.1093/ehjdh/ztac037 | Efficacy of digital health interventions on depression and anxiety in patients with cardiac disease: a systematic review and meta-analysis |
| https://doi.org/10.1161/circulationaha.123.067599 | One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial |
| https://doi.org/10.1093/eurheartj/ehaf369 | Atrial fibrillation in former world-class rowers: role of environmental and genetic factors |
| https://doi.org/10.1136/bmjsem-2023-001541 | Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial |
| https://doi.org/10.1093/eurjpc/zwae179 | Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT |
| https://doi.org/10.1016/j.jacc.2025.03.535 | 3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation |
| https://doi.org/10.1016/j.jcmg.2025.04.009 | Prediction of Left Ventricular Filling Pressures Using Natural Shear Waves |
| https://doi.org/10.1093/eurjpc/zwaf537 | A digitally supported shared decision-making approach for patients during cardiac rehabilitation: a randomized controlled trial |
| https://doi.org/10.1016/j.jacc.2026.03.021 | Sirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis |
| https://doi.org/10.1517/14656566.2014.881800 | Treatment of bacterial vaginosis: what we have and what we miss |
| https://doi.org/10.1152/ajpendo.00138.2012 | Neuromuscular electrical stimulation increases muscle protein synthesis in elderly type 2 diabetic men |
| https://doi.org/10.1016/j.ijcard.2016.08.303 | Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire |
| https://doi.org/10.1161/circulationaha.116.023952 | A Critical Appraisal of Aspirin in Secondary Prevention |
| https://doi.org/10.1002/(sici)1097-0304(199608)38:4<352::aid-ccd5>3.0.co;2-6 | Frequency of a positive modified Allen's test in 1,000 consecutive patients undergoing cardiac catheterization |
| https://doi.org/10.1016/j.ahj.2016.01.021 | Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction |
| https://doi.org/10.1016/j.ahj.2016.01.015 | Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial |
| https://doi.org/10.1177/0269215509353262 | Long-term effect of rehabilitation in coronary artery disease patients: randomized clinical trial of the impact of exercise volume |
| https://doi.org/10.1016/j.ahj.2018.07.006 | Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE-TAVI AF trial |
| https://doi.org/10.1016/j.jcin.2019.07.014 | Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention |
| https://doi.org/10.2165/11599590-000000000-00000 | Effect of Acute Endurance and Resistance Exercise on Endocrine Hormones Directly Related to Lipolysis and Skeletal Muscle Protein Synthesis in Adult Individuals with Obesity |
| https://doi.org/10.1016/j.jcin.2017.09.014 | Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management |
| https://doi.org/10.1093/ehjcvp/pvaa106 | PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY |
| https://doi.org/10.1093/eurheartj/ehu161 | Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial |
| https://doi.org/10.1177/1474515119856207 | Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) |